Dislog Group acquires 70% stake in Afrobiomedic

Dislog Group signed a memorandum of understanding to acquire 70% of the capital of Afrobiomedic, a Moroccan medical device company specializing in cardiology, as part of its healthcare division expansion.

“We believe in the potential for industrial, human and operational synergies around a common project focused on innovation and impact.”dislogroup.com

• 1 source
• dislogroup.comDislog Group renforce son pôle santé avec l’entrée au capital de Afrobiomedic - DISLOG GROUPApr 7, 2025

Summarized from public sources; check the original articles before acting on it.